Related Experiment Videos

Acute glomerular thrombosis with CsA treatment

N Muirhead1, D J Hollomby, P A Keown

  • 1University Hospital, London, Ontario, Canada.

Renal Failure
|January 1, 1987
PubMed

Insights

Cyclosporin A (CsA) can cause rare glomerular thrombosis in kidney transplant patients, leading to acute kidney injury. Prompt CsA withdrawal and streptokinase therapy reversed the condition, highlighting a critical, though speculative, CsA side effect.

Area of Science:

  • Nephrology
  • Transplantation Medicine
  • Pharmacology

Background:

  • Cyclosporin A (CsA) is a vital immunosuppressant in organ transplantation.
  • Nephrotoxicity remains a significant concern with CsA therapy.

Observation:

  • A case of acute glomerular thrombosis in a renal transplant recipient receiving CsA is presented.
  • This thrombosis led to acute renal failure.

Findings:

  • The patient's acute renal failure reversed after discontinuing CsA and receiving intra-arterial streptokinase.
  • CsA-induced capillary thrombosis is a rare complication, potentially mimicking acute rejection post-transplant.

Implications:

  • This case underscores the importance of recognizing CsA-induced glomerular thrombosis.
  • Early diagnosis and intervention, including CsA withdrawal and thrombolytic therapy, can be crucial for renal recovery.
  • The precise etiology of CsA-induced glomerular capillary thrombosis requires further investigation.

Related Concept Videos